12:04 PM EST - Oncolytics Biotech Inc. : Announced a collaboration with the Keck School of Medicine of University of Southern California (USC) using pelareorep in combination with Keytruda®, Velcade® and dexamethasone, to treat multiple myeloma. Oncolytics Biotech Inc.
shares T.ONC are trading up $1.07 at $10.10.
